Papers - SATO Mitsuo
-
Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome. Reviewed
Majima S, Okachi S, Asano M, Wakahara K, Hashimoto N, Sato M, Ishigami M, Hasegawa Y.
Intern Med. Vol. 57 page： 2371-2375 2018.8
-
eIF2β, a Subunit of Translation-Initiation Factor EIF2, Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.
Tanaka I, Sato M (corresponding author), Kato T, Goto D, Kakumu T, Miyazawa A, Yogo N, Hase T, Morise M, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV, Coombes KR, Kondo M, Hasegawa Y.
Cancer Sci. page： 10.1111/cas.13602. 2018.4
-
Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer Reviewed
Shotaro Okachi, Kazuyoshi Imaizumi, Naoyuki Imai, Takahiro Shimizu, Tetsunari Hase, Masahiro Morise, Naozumi Hashimoto, Mitsuo Sato, Yoshinori Hasegawa
European Geriatric Medicine Vol. 9 page： 255-262 2018.2
-
Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty.
Sato M, Okachi S, Fukihara J, Shimoyama Y, Wakahara K, Sakakibara T, Hase T, Onishi Y, Ogura Y, Maeda O, Hasegawa Y.
Intern Med. page： 10.2169/internalmedicine.9718-17. 2017.12
-
Regulation of PD-L1 expression by matrix stiffness in lung cancer cells. Reviewed
Miyazawa A, Ito S, Asano S, Tanaka I, Sato M, Kondo M, Hasegawa Y
Biochemical and biophysical research communications 2017.12
-
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Reviewed
Kakumu T, Sato M (corresponding author), Goto D, Kato T, Yogo N, Hase T, Morise M, Fukui T, Yokoi K, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV6, Coombes KR, Kondo M, Hasegawa Y
Cancer Sci. Vol. 108 page： 732-743 2017.4
-
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. Reviewed
Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD.
J Clin Invest. 2016.8
-
Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. Reviewed
Vol. 10 page： e0134842 2015.8
-
Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. Reviewed
Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E, Sekido Y, Kondo M, Hasegawa Y.
Cancer Med. Vol. 4 page： 551-564 2015.4
-
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Reviewed
Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, Ramirez RD, Tang H, Dimaio JM, Gao B, Xie Y, Wistuba II, Gazdar AF, Shay JW, Minna JD.
page： Epub ahead of print 2013
-
Primary prophylaxis indication for docetaxel induced febrile neutropenia in elderly patients with non-small cell lung cancer
Akira Matsui;Masahiro Morise;Ichidai Tanaka;Sachiko Ozone;Reiko Matsuzawa;Junji Koyama;Tetsunari Hase;Naozumi Hashimoto;Mitsuo Sato;Yoshinori Hasegawa
Cancer Investigation Vol. In press ( In press ) page： 1-19 2020.8
-
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. Reviewed
Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.
Lung Cancer. Vol. 128 page： 20-25 2018.12
-
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. Reviewed
Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, Cobb MH.
Proc Natl Acad Sci U S A. Vol. 110 ( 16 ) page： 6524-9 2013
-
(Review article) Emerging evidence of Epithelial-to-Mesenchymal Transition in lung carcinogenesis. Invited Reviewed
Sato M, Shames DS, Hasegawa Y.
Respirology. 2012
-
Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion. Reviewed
Mizutani T, Morise M, Ito Y, Hibino Y, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y.
Am J Respir Cell Mol Biol Vol. 47 page： 645 2012
-
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer. Reviewed
Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M.
Oncogene. page： 10.1038/onc 2012
-
NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition. Reviewed
Osborne JK, Larsen JE, Gonzales JX, Shames DS, Sato M, Wistuba II, Girard L, Minna JD, Cobb MH.
Oncogenesis 2013
-
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Reviewed
Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y.
Int J Cancer. 2012
-
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Reviewed
Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S, Girard L, Sato M, Kaira K, Ishizuka T, Gazdar AF, Minna JD, Mori M.
Int J Cancer. Vol. 130 page： 1733 2012
-
STIM1 regulates platelet-derived growth factor-induced migration and Ca2+ influx in human airway smooth muscle cells. Reviewed
Suganuma N, Ito S, Aso H, Kondo M, Sato M, Sokabe M, Hasegawa Y.
PLoS One Vol. 7 page： e45056 2012